See also this year's filing and all EDGAR filings for this company.
PDF Report 0001016504_2022_Integrated_Biopharma_INC.pdf
Logs
Graph
Absolute values for 0001016504, Integrated Biopharma INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 17,998,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,742,000 |
| 3 | remainder_Assets | 5,700,000 |
| 4 | LiabilitiesCurrent | 9,236,000 |
| 5 | LiabilitiesNoncurrent | 1,870,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 53,884,669 |
| 8 | SellingGeneralAndAdministrativeExpense | 3,675,139 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | -785,378 |
| 11 | remainder_Revenues | 62,986,161 |
| 12 | remainder_NetIncome | 1,447,309 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 25,440,000 |
| 1 | Liabilities | 11,106,000 |
| 2 | Expenses | 56,774,430 |
| 3 | Revenues | 62,986,161 |
| 4 | StockholdersEquity | 14,334,000 |
| 5 | NetIncome | 7,659,040 |
| 6 | ComprehensiveNetIncome | 7,659,040 |
| 7 | BaseVar | 78,876,950 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.13 |
| 9 | EconomicCapitalRatio | 3.11 |
Edgar->Model Mapping
Feature Distribution
Change over Time
